The small molecule drug arimoclomol (Miplyffa) has got the green light from the U.S. Food and Drug Administration (FDA) for ...
The US biotech’s neurological drug candidate showed a reduction in disease progression of at least 50% and the company will ...
The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...
The series A financing will enable Nura Bio to advance its lead drug candidate into the next stage of clinical trials, ...
This content is provided by Almac Group, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com Related categories: Analytical testing, QC Solid phase ...
The series A financing will enable Nura Bio to advance its lead drug candidate into the next stage of clinical trials, shortly after successfully completing a first phase 1 clinical trial.
She brings her global experience across multiple therapeutic areas to her current role leading operations at YPrime. In this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback